First Trust Advisors LP Pro Phase Labs, Inc. Transaction History

First Trust Advisors LP

  • $101 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$7.15 - $9.78 $15,930 - $21,789
2,228 Added 6.35%
37,333 $271,000
Q1 2023

May 15, 2023
BUY
$6.62 - $9.57 $17,728 - $25,628
2,678 Added 8.26%
35,105 $267,000
Q4 2022

Feb 09, 2023
SELL
$8.78 - $12.47 $14,697 - $20,874
-1,674 Reduced 4.91%
32,427 $312,000
Q3 2022

Nov 14, 2022
BUY
$8.96 - $14.7 $305,544 - $501,284
34,101 New
34,101 $385,000

Others Institutions Holding PRPH

# of Institutions
27
Shares Held
1.71M
Call Options Held
0
Put Options Held
0
View Full List

About ProPhase Labs, Inc.

PRPH Quotes by TradingView
  • Ticker PRPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 16,024,400
  • Market Cap $10.1M
  • Description
  • ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...
More about PRPH
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email